Search - tctmd.com

Displaying 21 - 31 of 31

Sort: Relevancy | Date

News Industry News

Early Human Cases With Edwards FORMA Tricuspid Repair System Presented At TCT

October 14, 2015

News Industry News

Mitralign to Provide Update on Transcatheter Tricuspid Repair at TCT 2015

October 12, 2015

News Industry News

Valtech's CE Mark-Approved Cardioband® for Transcatheter Mitral Valve Repair to Be Highlighted at the 2015 Transcatheter Cardiovascular Therapeutics Annual Meeting

October 11, 2015

News Industry News

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

September 14, 2015

News Industry News

Mitralign Receives FDA Approval for Percutaneous Tricuspid Repair Early Feasibility Study

August 31, 2015

News Industry News

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

August 24, 2015

News Industry News

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

July 27, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Industry News

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

June 26, 2015

News Industry News

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

June 22, 2015

News Industry News

UH Case Medical Center first in Ohio to implant new ventricular assist device

June 04, 2015

Advertisement

Early Human Cases With Edwards FORMA Tricuspid Repair System Presented At TCT

Mitralign to Provide Update on Transcatheter Tricuspid Repair at TCT 2015

Valtech's CE Mark-Approved Cardioband® for Transcatheter Mitral Valve Repair to Be Highlighted at the 2015 Transcatheter Cardiovascular Therapeutics Annual Meeting

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

Mitralign Receives FDA Approval for Percutaneous Tricuspid Repair Early Feasibility Study

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

UH Case Medical Center first in Ohio to implant new ventricular assist device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content